| | |
| Clinical data | |
|---|---|
| Other names | 4-TM; Thiomescaline; 3,5-Dimethoxy-4-methylthiophenethylamine; 4-Methylthio-3,5-dimethoxyphenethylamine; 3-MeO-4-MeS-5-MeO-PEA |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 30–60 minutes [1] [2] |
| Duration of action | 10–15 hours [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO2S |
| Molar mass | 227.32 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Thiomescaline (4-TM), or simply thiomescaline, also known as 3,5-dimethoxy-4-methylthiophenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline (3,4,5-trimethoxyphenethylamine). [1] [3] [4] [2] [5] It is the analogue of mescaline in which the methoxy group at the 4 position has been replaced with a methylthio group. [1] [3] [4] [5] The drug is one of two possible thiomescaline (TM) positional isomers, the other being 3-thiomescaline (3-TM). [1] [3] [4] [5]
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 4-TM's dose as 20 to 40 mg orally and its duration as 10 to 15 hours. [1] [3] [4] [2] [5] Its onset is 30 to 60 minutes. [1] [2] The drug has about 10 times the potency of mescaline. [1] [3] [4] [5] [6] [7] [8] The effects of 4-TM have been reported to include little color enhancement, closed-eye imagery, fantasy, feeling strange, feelings of unreality, seeing reality like a Möbius strip, introspection, insights, lightheadedness, physical uneasiness, tremor, abdominal cramps, walking difficulty, appetite loss, and some tactile numbness. [1] [2] [5] Shulgin described it as a "mixed bag of responses". [1] It was described as being more similar in its effects to LSD than to mescaline and as being similar in effects to the Aleph series. [1] [2]
The chemical synthesis of 4-TM has been described. [1] [5] [2]
4-TM was first synthesized and tested in 1977 and was described in the literature by Shulgin and colleagues in 1978. [4] [2] [5] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991. [1]
With the simple transformation of the 4-MeO in mescaline (22) to a 4-EtO group, i.e. escaline (70), a five times more potent analogue is obtained (Figure 5).[3] An even more dramatic increase of human potency has been observed with a 4-O to 4-S substitution. 4-Thiomescaline (4-TM, 71) is one order of magnitude more potent than mescaline.[3] It seems that the 5-HT2A receptor affinities do not increase sufficiently by these structural modifications to explain the increased human potency; the enhanced lipophilicity and receptor activation could also play an important role.[85]
A simple substitution of the 4-MeO group on mescaline (5; Figure 2) to a 4-S group, leads to 4-thiomescaline (4-TM; 10), an analogue that has been shown to increase human potency 10-fold compared to 5 (active dose of 10 in humans = 20–40 mg) (Shulgin and Shulgin 1991).